[{"id":"bed7c71a-58e8-493a-9ca3-5530a1dbdfd2","acronym":"XTX202-01","url":"https://clinicaltrials.gov/study/NCT05052268","created_at":"2023-06-09T18:07:11.283Z","updated_at":"2024-07-02T16:35:11.122Z","phase":"Phase 1/2","brief_title":"XTX202 in Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT05052268 - XTX202-01","lead_sponsor":"Xilio Development, Inc.","biomarkers":" BRAF","pipe":" | ","alterations":" BRAF mutation • BRAF V600","tags":["BRAF"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRAF mutation • BRAF V600"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e XTX202"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 189","initiation":"Initiation: 01/18/2022","start_date":" 01/18/2022","primary_txt":" Primary completion: 02/08/2026","primary_completion_date":" 02/08/2026","study_txt":" Completion: 02/08/2026","study_completion_date":" 02/08/2026","last_update_posted":"2024-04-05"}]